| Group I | Group II | Test Value | P-Value | Sig. | |
No. = 15 | No. = 5 | |||||
| Mean ± SD | 9.60 ± 1.67 | 9.27 ± 2.58 | 0.268 | 0.791 | NS |
Range | 6 - 15 | 8 - 12 | ||||
<7 day | 5 (33.3%) | 0 (0.0%) | 2.222 | 0.136 | NS | |
≥7 day | 10 (66.7%) | (100.0%) | ||||
Time starting medication from onset of first symptoms (days) | Mean ± SD | 2.80 ± 1.30 | 5.93 ± 2.872 | −2.333 | 0.031 | S |
Range | 2 - 5 | 2 - 12 | ||||
| Mean ± SD | 3.73 ± 0.70 | 6.00 ± 4.85 | 1.854 | 0.080 | NS |
Range | 3 - 5 | 1 - 14 | ||||
<4 weeks | 13 (86.7%) | 2 (40.0%) | 4.356 | 0.037 | S | |
≥4 weeks | 2 (13.3%) | 3 (60.0%) | ||||
| No | 14 (93.3%) | 2 (40.0%) | 6.667 | 0.010 | S |
Yes | 1 (6.7%) | 3 (60.0%) | ||||
| Median (IQR) | 11 (11 - 11) | 3 (2 - 3) | -1.414≠ | 0.157 | NS |
Range | 11 - 11 | 2 - 3 | ||||
<3 | 0 (0.0%) | 3 (100.0%) | 4.000 | 0.046 | S | |
≥3 | 1 (100.0%) | 0 (0.0%) |